Giving patients with tuberculosis (TB) lower doses of the bedaquiline together with verapamil might lead to the same antibacterial effects as higher toxic doses of bedaquiline, according to a study of mice published in Antimicrobial Agents and Chemotherapy. The combination could potentially shorten treatment time, reduce the side effects of bedaquiline, and improve patient outcomes. Read more and read the study abstract.
© 2021 HealthCom Media All rights reserved. No part of this website or publication may be reproduced, stored, or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the copyright holder